Pulmonary embolism treatment approach: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
{{familytree | | | | | | | | GPa | GPa='''Is [[anticoagulation]] contraindicated ?'''}} | {{familytree | | | | | | | | GPa | GPa='''Is [[anticoagulation]] contraindicated ?'''}} | ||
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | {{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }} | ||
{{familytree | | |JOE | {{familytree | | |JOE| | | | | | | |SIS| | | JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | ||
{{familytree | | | |! | {{familytree | | | |!| | | | | | | | | |!| }} | ||
{{familytree | | |MOM | {{familytree | | |MOM| | | | | | | | SIS | | |MOM=[[Pulmonary embolism diagnosis|'''Diagnostic evaluation''']]|SIS=Anticoagulate with SC [[LMWH]] or IV [[Heparin|UFH]]}} | ||
{{familytree | |,|-|^|. | {{familytree | |,|-|^|.| | | | | | | | |!| }} | ||
{{familytree |GPa| |JOE | {{familytree |GPa| |JOE| | | | | |A01|GPa=PE excluded|JOE='''PE confirmed'''|A01=[[Pulmonary embolism diagnosis|'''Diagnostic evaluation''']]}} | ||
{{familytree | |!| | | |! | {{familytree | |!| | | |!| | | | | |,|-|^|.| }} | ||
{{familytree |C01| |C02 | {{familytree |C01| |C02| | |C03| |C04|C01=No further Treatment|C02='''[[Inferior vena cava filter#Pulmonary embolism inferior vena cava filter|Inferior vena cava filter]]'''|C03=PE excluded|C04='''PE confirmed'''}} | ||
{{familytree | {{familytree | | | | | | | | | | |!| | | |!|}} | ||
{{familytree | {{familytree | | | | | | | | | |SIS| |B02|SIS=Discontinue Anticoagulants|B02='''Clinicaly severe enough to need [[Thrombolysis]]'''}} | ||
{{familytree | {{familytree | | | | | | | | | | | | |,|-|^|-|.| }} | ||
{{familytree | {{familytree | | | | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS=No}} | ||
{{familytree | {{familytree | | | | | | | | | | | | |!| | | |!| }} | ||
{{familytree | {{familytree | | | | | | | | | | | |SIS| |B02|SIS='''Is [[thrombolytic]] Contraindicated?'''|B02=Continue Anticoagulants}} | ||
{{familytree | {{familytree | | | | | | | | | | |,|-|^|-|.| }} | ||
{{familytree | {{familytree | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}} | ||
{{familytree | {{familytree | | | | | | | | | | |!| | | |!| }} | ||
{{familytree | {{familytree | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02='''Hold Anticoagulation, Give Thrombolytics then resume Anticoagulations'''}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | |!| | | |}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | |SIS|SIS=Patient show Clinically Improvement}} | ||
{{familytree | {{familytree | | | | | | | | | | | | |,|-|^|-|.| }} | ||
{{familytree | {{familytree | | | | | | | | | | | |JOE| |SIS|JOE='''No'''|ME=Inconclusive study|SIS='''Yes'''}} | ||
{{familytree | {{familytree | | | | | | | | | | | | |!| | | |!| }} | ||
{{familytree | {{familytree | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02=Continue Anticoagulation}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:57, 4 November 2011
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism treatment approach On the Web |
|
Directions to Hospitals Treating Pulmonary embolism treatment approach |
|
Risk calculators and risk factors for Pulmonary embolism treatment approach |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Pulmonary embolism (PE) is a potentially lethal condition, with a mortality rate close to 30 percent without treatment. Thus prompt and effective therapy is utmost important. In most cases, anticoagulant therapy is the mainstay of treatment. Acutely, supportive treatments, such as oxygen or analgesia, are often required.
Treatment Algorithm
| Stabilize the patient | |||||||||||||||||||||||||||||||||||||
| Is anticoagulation contraindicated ? | |||||||||||||||||||||||||||||||||||||
| Yes | No | ||||||||||||||||||||||||||||||||||||
| Diagnostic evaluation | Anticoagulate with SC LMWH or IV UFH | ||||||||||||||||||||||||||||||||||||
| PE excluded | PE confirmed | Diagnostic evaluation | |||||||||||||||||||||||||||||||||||
| No further Treatment | Inferior vena cava filter | PE excluded | PE confirmed | ||||||||||||||||||||||||||||||||||
| Discontinue Anticoagulants | Clinicaly severe enough to need Thrombolysis | ||||||||||||||||||||||||||||||||||||
| Yes | No | ||||||||||||||||||||||||||||||||||||
| Is thrombolytic Contraindicated? | Continue Anticoagulants | ||||||||||||||||||||||||||||||||||||
| Yes | No | ||||||||||||||||||||||||||||||||||||
| Surgical emblectomy or catheter based interventions | Hold Anticoagulation, Give Thrombolytics then resume Anticoagulations | ||||||||||||||||||||||||||||||||||||
| Patient show Clinically Improvement | |||||||||||||||||||||||||||||||||||||
| No | Yes | ||||||||||||||||||||||||||||||||||||
| Surgical emblectomy or catheter based interventions | Continue Anticoagulation | ||||||||||||||||||||||||||||||||||||